Oncology & Cancer

Targeting pancreatic cancer drug resistance

Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%. Novel therapies are urgently needed, as conventional and targeted approaches have not been successful and ...

Oncology & Cancer

Garlic oil may ease adverse effects of chemotherapy and radiation

(Medical Xpress)—Demand has grown recently to find more natural ways to reduce the adverse effects of the two major methods for cancer treatment, ionizing radiation and chemotherapy. A new study in the Journal of Food Science, ...

Oncology & Cancer

Inhalation therapy for lung cancer shows promise in study

(Medical Xpress)—Lung cancer kills about 1.5 million men and women around the world – more than the number of people who die from breast, colon, pancreatic and prostate cancers combined.

Oncology & Cancer

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs ...

Oncology & Cancer

Developments in TACE and SIRT treatment in patients

Data from a number of clinical trials presented today at the International Liver Congress 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma (HCC).

page 5 from 8